GMP細胞治療消耗品市場：製品タイプ別、細胞タイプ別、用途別、エンドユーザー別、地域別

世界のGMP細胞治療消耗品市場は、2024年に1,404万米ドルと推定され、2024年から2031年までのCAGRは28.2％を示し、2031年には8,003万米ドルに達すると予測されます。

図.GMP細胞治療消耗品市場シェア（%）、地域別、2024年

世界のGMP細胞治療消耗品市場の成長は、がんのような慢性疾患の有病率の増加が牽引しています。細胞治療には、患者やドナーの体内から細胞を抽出し、病気と闘うために細胞を改変することが含まれます。GMP消耗品は、細胞治療製品の開発・製造時に無菌性を確保し汚染を防ぐため、細胞治療手順において重要な役割を果たしています。細胞ベースの研究に対する資金提供の増加、慢性疾患にかかりやすい高齢者人口の増加、ヘルスケア支出の増大といった要因が、細胞治療におけるGMP消耗品の需要を世界的に押し上げる可能性があります。しかし、細胞治療開発に関連する高コストやGMP施設に関する厳しい規制ガイドラインが市場成長の妨げとなる可能性があります。

市場力学：

世界のGMP細胞治療消耗品市場の成長は、世界のがんやその他の慢性疾患の罹患率の上昇などの要因によって牽引されています。WHOの発表によると、2018年のがんの新規罹患者数は1,810万人、死亡者数は960万人に増加しています。このため、細胞治療のような高度な治療ソリューションの需要が高まり、GMP消耗品のニーズが高まっています。官民組織による細胞ベースの研究への投資の拡大は、市場の成長を促進する可能性があります。例えば、米国国立衛生研究所（National Institutes of Health）は2022年に1億5,000万米ドル以上を細胞療法研究に供与しました。しかし、細胞治療の開発とGMP施設の維持に関連する高コストが市場成長の妨げとなる可能性があります。GMP製造に関する厳しい規制基準は、細胞治療製品の幅広い商業化を妨げる可能性があります。さらに、細胞治療に関連する償還の問題が市場成長の妨げになる可能性があります。製造プロセスを簡素化するためのGMP消耗品における継続的な技術進歩や細胞治療の用途の増加は、市場プレーヤーに成長機会を提供することができます。

本調査の主な特徴

本レポートでは、世界のGMP細胞治療消耗品市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模と年間平均成長率（CAGR%）を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のGMP細胞治療消耗品市場における主要企業プロファイルを掲載しています。

主な企業は、Merck KGaA、Danaher Corporation、Sartorius AG、Thermo Fisher Scientific、General Electric、PBS Biotech、Meissner Filtration Productsなどです。

このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。

世界のGMP細胞治療消耗品市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界のGMP細胞治療消耗品市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 影響分析
• 主なハイライト
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ

第4章 世界のGMP細胞治療消耗品市場、製品タイプ別、2019年～2023年、（百万米ドル）

• 細胞培養培地とサプリメント
• 細胞分離および精製消耗品
• 凍結保存用消耗品
• 細胞導入消耗品
• その他の消耗品（実験器具、バイオリアクターなど）

第5章 世界のGMP細胞治療消耗品市場、細胞タイプ別、2019年～2023年、（百万米ドル）

• 幹細胞（胚性、人工多能性、成体）
• T細胞
• ナチュラルキラー（NK）細胞
• その他の細胞タイプ（樹状細胞、軟骨細胞など）

第6章 世界のGMP細胞治療消耗品市場、用途別、2019年～2023年、（百万米ドル）

• 腫瘍学
• 再生医療
• 神経学
• 心臓血管
• 免疫学
• その他の用途

第7章 世界のGMP細胞治療消耗品市場、エンドユーザー別、2019年～2023年、（百万米ドル）

• バイオ医薬品企業
• 契約製造組織（CMO）
• 学術調査機関
• 病院と診療所
• その他

第8章 世界のGMP細胞治療消耗品市場、地域別、2019年～2023年、（百万米ドル）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Thermo Fisher Scientific Inc.
• Lonza Group
• Merck KGaA
• Corning Inc.
• Sartorius AG
• Danaher Corporation
• Miltenyi Biotec
• Stemcell Technologies Inc.
• GE Healthcare
• Takara Bio Inc.
• Bio-Techne Corporation
• HiMedia Laboratories
• Eppendorf AG
• Avantor, Inc.
• Beckman Coulter, Inc.
• Terumo BCT, Inc.
• Roche Diagnostics
• Irvine Scientific
• Fujifilm Irvine Scientific, Inc.
• CellGenix GmbH

第10章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫した機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global GMP cell therapy consumables market is estimated to be valued at USD 14.04 Mn in 2024 and is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031.

Figure. GMP Cell Therapy Consumables Market Share (%), By Region, 2024

Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in cell therapy procedures as these ensure sterility and prevent contamination during development and manufacturing of cell therapy products. Factors such as rising funding for cell-based research, growing geriatric population susceptible to chronic illnesses and augmenting healthcare expenditure can boost demand for GMP consumables in cell therapy globally. However, high costs associated with cell therapy developments and stringent regulatory guidelines for GMP facilities can hamper the market growth.

Market Dynamics:

Global GMP cell therapy consumables market growth is driven by factors such as rising incidence of cancer and other chronic illnesses worldwide. As per WHO, cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. This has boosted demand for advanced treatment solutions like cell therapy, thus, boosting the need for GMP consumables. Growing investments in cell-based research by public-private organizations can drive the market growth. For instance, National Institutes of Health granted over US$ 150 million towards cell therapy research in 2022. However, high costs associated with cell therapy development and maintenance of GMP facilities can hamper the market growth. Strict regulatory standards for GMP manufacturing can hamper the wider commercialization of cell therapy products. Moreover, reimbursement issues related to cell therapies can hamper the market growth. Ongoing technological advancements in GMP consumables to simplify manufacturing processes and rising applications of cell therapies can provide growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global GMP cell therapy consumables market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global GMP cell therapy consumables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, General Electric, PBS Biotech, Meissner Filtration Products

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global GMP cell therapy consumables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell therapy consumables market

Detailed Segmentation-

• Product Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Cell Culture Media and Supplements
  • Cell Separation and Purification Consumables
  • Cryopreservation Consumables
  • Cell Transduction Consumables
  • Other Consumables (Labware, Bioreactors, etc.)
• Cell Type Insights (Revenue, USD Mn, 2019 - 2031)
  • Stem Cells (Embryonic, Induced Pluripotent, Adult)
  • T-Cells
  • Natural Killer (NK) Cells
  • Other Cell Types (Dendritic Cells, Chondrocytes, etc.)
• Application Insights (Revenue, USD Mn, 2019 - 2031)
  • Oncology
  • Regenerative Medicine
  • Neurology
  • Cardiovascular
  • Immunology
  • Other Applications
• End User Insights (Revenue, USD Mn, 2019 - 2031)
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Academic and Research Institutions
  • Hospitals and Clinics
  • Others
• By Regional Insights (Revenue, USD Mn 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Thermo Fisher Scientific Inc.
  • Lonza Group
  • Merck KGaA
  • Corning Inc.
  • Sartorius AG
  • Danaher Corporation
  • Miltenyi Biotec
  • Stemcell Technologies Inc.
  • GE Healthcare
  • Takara Bio Inc.
  • Bio-Techne Corporation
  • HiMedia Laboratories
  • Eppendorf AG
  • Avantor, Inc.
  • Beckman Coulter, Inc.
  • Terumo BCT, Inc.
  • Roche Diagnostics
  • Irvine Scientific
  • Fujifilm Irvine Scientific, Inc.
  • CellGenix GmbH

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global GMP Cell Therapy Consumables Market, By Product Type
  • Global GMP Cell Therapy Consumables Market, By Cell Type
  • Global GMP Cell Therapy Consumables Market, By Application
  • Global GMP Cell Therapy Consumables Market, By End User
  • Global GMP Cell Therapy Consumables Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global GMP Cell Therapy Consumables Market, By Product Type, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cell Culture Media and Supplements
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Cell Separation and Purification Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Cryopreservation Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Cell Transduction Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Other Consumables (Labware, Bioreactors, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global GMP Cell Therapy Consumables Market, By Cell Type, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Stem Cells (Embryonic, Induced Pluripotent, Adult)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• T-Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Natural Killer (NK) Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Other Cell Types (Dendritic Cells, Chondrocytes, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global GMP Cell Therapy Consumables Market, By Application, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020- 2031
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global GMP Cell Therapy Consumables Market, By End User, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Contract Manufacturing Organizations (CMOs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global GMP Cell Therapy Consumables Market, By Region, 2019 - 2031, (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2019 - 2031, (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
  • Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Lonza Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
• Corning Inc.
• Sartorius AG
• Danaher Corporation
• Miltenyi Biotec
• Stemcell Technologies Inc.
• GE Healthcare
• Takara Bio Inc.
• Bio-Techne Corporation
• HiMedia Laboratories
• Eppendorf AG
• Avantor, Inc.
• Beckman Coulter, Inc.
• Terumo BCT, Inc.
• Roche Diagnostics
• Irvine Scientific
• Fujifilm Irvine Scientific, Inc.
• CellGenix GmbH

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us